IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Seeds and traits

Novozymes Earnings Up 4%; CEO Expects Higher Growth for Full Year (update)

8:09 AM MDT | April 25, 2012 | Alex Scott

Novozymes (Bagsvaerd, Denmark), an enzymes technology firm, has recorded first quarter net profits for the year of DK510 million ($91 million), up 4% compared with the same period one year ago. Corresponding sales increased 2% to DK2.7 billion. Organic sales for the quarter were flat compared with an 8% increase in the year-ago first quarter. Sales in local currencies fell 1% with the year-ago period. Despite the low sales and earnings figures, Novozymes CEO Steen Riisgaard says that the financial results are “in line with expectations” and that it...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa